173 related articles for article (PubMed ID: 25577248)
1. Identification of cystatin SN as a novel biomarker for pancreatic cancer.
Jiang J; Liu HL; Liu ZH; Tan SW; Wu B
Tumour Biol; 2015 May; 36(5):3903-10. PubMed ID: 25577248
[TBL] [Abstract][Full Text] [Related]
2. Let‑7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.
Jiang J; Liu HL; Tao L; Lin XY; Yang YD; Tan SW; Wu B
Int J Oncol; 2018 Aug; 53(2):781-790. PubMed ID: 29845224
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.
Choi EH; Kim JT; Kim JH; Kim SY; Song EY; Kim JW; Kim SY; Yeom YI; Kim IH; Lee HG
Clin Chim Acta; 2009 Aug; 406(1-2):45-51. PubMed ID: 19463800
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Dai DN; Li Y; Chen B; Du Y; Li SB; Lu SX; Zhao ZP; Zhou AJ; Xue N; Xia TL; Zeng MS; Zhong Q; Wei WD
J Mol Med (Berl); 2017 Aug; 95(8):873-886. PubMed ID: 28523467
[TBL] [Abstract][Full Text] [Related]
5. Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma.
Yang J; Luo G; Li C; Zhao Z; Ju S; Li Q; Chen Z; Ding C; Tong X; Zhao J
BMC Cancer; 2022 May; 22(1):589. PubMed ID: 35637432
[TBL] [Abstract][Full Text] [Related]
6. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
[TBL] [Abstract][Full Text] [Related]
7. Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity.
Kim JT; Lee SJ; Kang MA; Park JE; Kim BY; Yoon DY; Yang Y; Lee CH; Yeom YI; Choe YK; Lee HG
Cell Death Dis; 2013 Dec; 4(12):e974. PubMed ID: 24357805
[TBL] [Abstract][Full Text] [Related]
8. Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation.
Oh SS; Park S; Lee KW; Madhi H; Park SG; Lee HG; Cho YY; Yoo J; Dong Kim K
Cell Death Dis; 2017 Apr; 8(4):e2729. PubMed ID: 28383558
[TBL] [Abstract][Full Text] [Related]
9. Novel expression of CST1 as candidate senescence marker.
Keppler D; Zhang J; Bihani T; Lin AW
J Gerontol A Biol Sci Med Sci; 2011 Jul; 66(7):723-31. PubMed ID: 21636832
[TBL] [Abstract][Full Text] [Related]
10. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
Lai Y; Wang Y; Wu Y; Wu M; Xing S; Xie Y; Chen S; Li X; Zhang A; He Y; Li H; Dai S; Wang J; Lin S; Bai Y; Du H; Liu W
Cancer Control; 2022; 29():10732748221104661. PubMed ID: 35653624
[TBL] [Abstract][Full Text] [Related]
12. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Wang J; Guo X; Xie C; Jiang J
Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
[TBL] [Abstract][Full Text] [Related]
13. Expression of type 2 cystatin genes CST1-CST5 in adult human tissues and the developing submandibular gland.
Dickinson DP; Thiesse M; Hicks MJ
DNA Cell Biol; 2002 Jan; 21(1):47-65. PubMed ID: 11879580
[TBL] [Abstract][Full Text] [Related]
14. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
Zhu H; Qin H; Li DM; Liu J; Zhao Q
Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
[TBL] [Abstract][Full Text] [Related]
15. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cystatin SN associated nomograms in patients with colorectal cancer.
Li T; Xiong Q; Zou Z; Lei X; Jiang Q; Liu D
Oncotarget; 2017 Dec; 8(70):115153-115163. PubMed ID: 29383149
[TBL] [Abstract][Full Text] [Related]
17. Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis.
Nocera AL; Mueller SK; Workman AD; Wu D; McDonnell K; Sadow PM; Amiji MM; Bleier BS
J Allergy Clin Immunol; 2022 Oct; 150(4):872-881. PubMed ID: 35660375
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer.
Peng W; Jiang A
Biomed Pharmacother; 2016 Oct; 83():712-717. PubMed ID: 27470572
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
20. Validation of serum cystatin SN detection for diagnosis and poor prognosis of esophageal squamous cell carcinoma.
Pi Y; Lin S; Ren X; Wang L; Song Y; Wu Z; Lai Y
Front Oncol; 2024; 14():1337707. PubMed ID: 38414741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
